Ausgewählte Datenmodelle

Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.

13 Suchergebnisse.
Relevanz Bewertung Neue zuerst Alte zuerst

Study SHIP-START_SHIP2_IMB - s2.diffusio_no

- 26.10.24 - 15 Formulare, 1 Itemgruppe, 54 Datenelemente, 2 Sprachen
Itemgruppe: s2.diffusio_no
SHIP Study https://doi.org/10.1093/ije/dyac034

s2.diffusio

1 Itemgruppe 17 Datenelemente

s2.spiromet

1 Itemgruppe 8 Datenelemente

s2.spimes

1 Itemgruppe 31 Datenelemente

s2.breath

1 Itemgruppe 7 Datenelemente

s2.bpgopd

1 Itemgruppe 11 Datenelemente

s2.abimes

1 Itemgruppe 18 Datenelemente

Study SHIP-START_SHIP3_IMB - s3.spiread

- 26.10.24 - 15 Formulare, 1 Itemgruppe, 11 Datenelemente, 2 Sprachen
Itemgruppe: s3.spiread
SHIP Study https://doi.org/10.1093/ije/dyac034

s3.vaeopd

1 Itemgruppe 41 Datenelemente

s3.spiexp

1 Itemgruppe 329 Datenelemente

s3.lufios

1 Itemgruppe 128 Datenelemente

s3.lufopd

1 Itemgruppe 58 Datenelemente

s3.finb

1 Itemgruppe 19 Datenelemente

s3.pre

1 Itemgruppe 34 Datenelemente

Study SHIP-TREND_TREND0_IMB - t0.spiread

- 26.10.24 - 15 Formulare, 1 Itemgruppe, 34 Datenelemente, 2 Sprachen
Itemgruppe: t0.spiread
SHIP Study https://doi.org/10.1093/ije/dyac034

t0.bpgopd

1 Itemgruppe 11 Datenelemente

t0.spiexp

1 Itemgruppe 29 Datenelemente

t0.diffusio

1 Itemgruppe 17 Datenelemente

t0.imbintro

1 Itemgruppe 9 Datenelemente

t0.spiromet

1 Itemgruppe 8 Datenelemente

t0.diffusio_no

1 Itemgruppe 54 Datenelemente

Study SHIP-TREND_TREND1_IMB - t1.spiread

- 26.10.24 - 18 Formulare, 1 Itemgruppe, 11 Datenelemente, 2 Sprachen
Itemgruppe: t1.spiread
SHIP Study https://doi.org/10.1093/ije/dyac034

t1.vaeopd

1 Itemgruppe 41 Datenelemente

t1.biames

1 Itemgruppe 14 Datenelemente

t1.lufopd

1 Itemgruppe 58 Datenelemente

t1.ortho

1 Itemgruppe 9 Datenelemente

t1.finb

1 Itemgruppe 23 Datenelemente

t1.pre

1 Itemgruppe 34 Datenelemente

Spirometry Cardiovascular Health Study (CHS)

- 11.07.16 - 1 Formular, 2 Itemgruppen, 42 Datenelemente, 1 Sprache
Itemgruppen: Spirometry, Date of interview
Documentation part: Record 11 Spirometry The Cardiovascular Health Study (CHS) was initiated by the National Heart, Lung and Blood Institute (NHLBI) in 1987 to determine the risk factors for development and progression of cardiovascular disease (CVD) in older adults, with an emphasis on subclinical measures. The study recruited 5,888 adults aged 65 or older at entry in four U.S. communities and conducted extensive annual clinical exams between 1989-1999 along with semi-annual phone calls, events adjudication, and subsequent data analyses and publications. Additional data were collected by studies ancillary to CHS. With the exception of annual clinic visits, these activities are still ongoing. Data obtained from: https://chs-nhlbi.org/ Permission granted by: Erika Enright.

clinic internal medicine B SHIP-START-3 SPI: operational data

- 20.09.21 - 1 Formular, 1 Itemgruppe, 23 Datenelemente, 2 Sprachen
Itemgruppe: SPI: operational data
SPI: operational data form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name SHIP.SHIP3.IMB.SPI.SPIOPD. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617 The English version of this form is under development.

clinic internal medicine B SHIP-START-3 SPI: reading data

- 03.07.21 - 1 Formular, 1 Itemgruppe, 11 Datenelemente, 2 Sprachen
Itemgruppe: SPI: reading data
SPI: reading data form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name SHIP.SHIP3.IMB.SPI.SPIREAD. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617 The English version of this form is under development.

clinic internal medicine B SHIP-Trend-1 SPI: reading data

- 21.01.21 - 1 Formular, 1 Itemgruppe, 11 Datenelemente, 2 Sprachen
Itemgruppe: SPI: reading data
SPI: reading data form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name TREND.TREND1.IMB.SPI.SPIREAD. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617 The English version of this form is under development.

clinic internal medicine B SHIP-Trend-1 SPI: operational data

- 21.01.21 - 1 Formular, 1 Itemgruppe, 23 Datenelemente, 2 Sprachen
Itemgruppe: SPI: operational data
SPI: operational data form of SHIP Study (Study of Health in Pomerania), conducted by the University Medicine of Greifswald. SHIP unique domain name TREND.TREND1.IMB.SPI.SPIOPD. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html. Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

clinic internal medicine B SHIP-Trend-0 BPG: spirometry

- 20.09.21 - 1 Formular, 1 Itemgruppe, 8 Datenelemente, 2 Sprachen
Itemgruppe: BPG: spirometry
BPG: spirometry form of SHIP Study (Study of Health in Pomerania), conducted by the University of Greifswald. SHIP unique domain name SHIP.SHIPTrend0.IMB.BPG.SPIROMET. ODM derived from https://www.fvcm.med.uni-greifswald.de/dd_service/data_use_explore.php. Further information: http://www2.medizin.uni-greifswald.de/cm/fv/ship.html.
 Publication granted by Prof. Völzke. Reference: Völzke H, et al. Cohort profile: the study of health in Pomerania. Int J Epidemiol. 2011;40(2):294-307. PMID: 20167617

Phase I Trial of Intravenous TNFR1 Antagonist GSK1995057 in Healthy Subjects - NCT01476046 - Spirometry

- 12.11.19 - 1 Formular, 3 Itemgruppen, 9 Datenelemente, 1 Sprache
Itemgruppen: Administrative Data, Dosing Date/Time, Spirometry
Study ID: 110951 Clinical Study ID: 110951 Study Title: A two-part, randomised, placebo-controlled study to investigate the safety, tolerability, pharmacokinetics and pharmacodynamics of single doses of intravenously infused GSK1995057 in healthy subjects. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT01476046 See https://clinicaltrials.gov/ct2/show/NCT01476046 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: N/A, Placebo Trade Name: N/A Study Indication: Respiratory Disorders This phase I trial primarily studies the safety and tolerability of ascending single intravenous doses of the selective TNFR1 antagonist GSK1995057 in healthy volunteers, and secondly explores the drug's pharmacodynamics, pharmacokinetics, concentration in lung epithelial lining fluid as well as its effect on immune system markers. The drug is hypothesized to be useful for Acute Lung Injury. The single-centre study consists of two parts A and B with seven cohorts/ten subcohorts in total. Part A includes ascending doses of the investigational product given to subjects negative or positive for pre-existing human anti-heavy chain variable domain (HAVH) antibodies (Cohorts 1 to 3 with Subcohorts 1a, 2a and 3a negative for HAVH and 1b, 2b, 3b positive for HAVH). Part B includes only subjects negative for HAVH, with ascending doses given to Cohorts 4 to 6. Cohort 7 receives the same dose as Cohort 6, but whereas the other Cohorts are single-blinded, Cohort 7 is open-label and additionally receives a bronchoalveolar lavage (BAL). The study consists of a Screening Visit (up to 56 days before Day 1, the day of the drug administration), Visits on Day -1, 1, 2, 3, 5, 7, 14, 28 and Follow-Up Visits on Day 57 and 85. This form contains information on the Spirometry which is performed at Screening, on Days 1, 2 and 28, in case of early withdrawal and as an unscheduled (repeat) assessment.

Bronchodilator Responsiveness (BDR) Protocol PhenX Toolkit

- 27.09.17 - 1 Formular, 5 Itemgruppen, 14 Datenelemente, 1 Sprache
Itemgruppen: PhenX - respiratory - bronchodilator responsiveness - BDR protocol, Pre - Bronchodilator Forced Expiratory Volume (FEV 1 ) in 1 second, Post - Bronchodilator Forced Expiratory Volume (FEV 1 ) in 1 second, Pre - Bronchodilator Forced Vital Capacity (FVC), Post - Bronchodilator Forced Vital Capacity (FVC)
A series of spirometry maneuvers is performed to obtain acceptable and reproducible results. An inhaled bronchodilator medication is administered, and a second series of spirometry maneuvers is performed. ODM derived from: https://cde.nlm.nih.gov Primary source: https://www.phenxtoolkit.org/ Recent publication: Hendershot, T., Pan, H., Haines, J., Harlan, W.R., Marazita, M.L., McCarty, C.A., Ramos, E.M., and Hamilton, C.M. (2015) Using the PhenX toolkit to add standard measures to a study. Curr. Protoc. Hum. Genet. 86:1.21.1-1.21.17. doi: 10.1002/0471142905.hg0121s86 Permission to publish granted by Carol M. Hamilton.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video